[go: up one dir, main page]

MX2010008019A - Nuevas imidazolinilmetil aril sulfonamidas. - Google Patents

Nuevas imidazolinilmetil aril sulfonamidas.

Info

Publication number
MX2010008019A
MX2010008019A MX2010008019A MX2010008019A MX2010008019A MX 2010008019 A MX2010008019 A MX 2010008019A MX 2010008019 A MX2010008019 A MX 2010008019A MX 2010008019 A MX2010008019 A MX 2010008019A MX 2010008019 A MX2010008019 A MX 2010008019A
Authority
MX
Mexico
Prior art keywords
novel
aryl sulfonamides
imidazolinylmethyl
imidazolinylmethyl aryl
methods
Prior art date
Application number
MX2010008019A
Other languages
English (en)
Inventor
Counde O'yang
Dennis Mitsugu Yasuda
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2010008019A publication Critical patent/MX2010008019A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere a un agonista parcial del receptor alfa-1A, el cual es representado por la fórmula (I) (ver fórmula (I)) y sales farmacéuticamente aceptables o solvatos del mismo. La invención se refiere además a composiciones farmacéuticas que contienen la fórmula I, a métodos para su uso como agentes terapéuticos y a métodos de preparación de las mismas.
MX2010008019A 2008-02-04 2009-01-26 Nuevas imidazolinilmetil aril sulfonamidas. MX2010008019A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2583608P 2008-02-04 2008-02-04
PCT/EP2009/050837 WO2009098133A1 (en) 2008-02-04 2009-01-26 Novel imidazolinylmethyl aryl sulfonamides

Publications (1)

Publication Number Publication Date
MX2010008019A true MX2010008019A (es) 2010-08-10

Family

ID=40456344

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008019A MX2010008019A (es) 2008-02-04 2009-01-26 Nuevas imidazolinilmetil aril sulfonamidas.

Country Status (12)

Country Link
US (1) US20090197933A1 (es)
EP (1) EP2238115B1 (es)
JP (1) JP2011511023A (es)
KR (1) KR20100096266A (es)
CN (1) CN101925579A (es)
AT (1) ATE531697T1 (es)
AU (1) AU2009211503A1 (es)
BR (1) BRPI0907495A2 (es)
CA (1) CA2711724A1 (es)
IL (1) IL206763A0 (es)
MX (1) MX2010008019A (es)
WO (1) WO2009098133A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021334327A1 (en) * 2020-08-27 2023-05-04 Curasen Therapeutics, Inc. α1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
KR100696561B1 (ko) * 2002-04-23 2007-03-19 에프. 호프만-라 로슈 아게 이미다졸린일메틸 아르알킬설폰아마이드

Also Published As

Publication number Publication date
EP2238115B1 (en) 2011-11-02
CA2711724A1 (en) 2009-08-13
WO2009098133A1 (en) 2009-08-13
EP2238115A1 (en) 2010-10-13
CN101925579A (zh) 2010-12-22
IL206763A0 (en) 2010-12-30
AU2009211503A1 (en) 2009-08-13
KR20100096266A (ko) 2010-09-01
ATE531697T1 (de) 2011-11-15
JP2011511023A (ja) 2011-04-07
BRPI0907495A2 (pt) 2019-02-26
US20090197933A1 (en) 2009-08-06

Similar Documents

Publication Publication Date Title
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
MX353209B (es) Antagonistas d2, metodos de sintesis y metodos de uso.
MX2009000884A (es) Derivados de piridizinona.
GEP20135992B (en) Sulfonamide derivatives
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
GEP20156348B (en) Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
MX2010009752A (es) Compuestos de oxadiazoantraceno para el tratamiento de diabetes.
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
EA200900135A1 (ru) Производные пиразола в качестве ингибиторов цитохрома р450
IL189191A0 (en) Thiazolyl piperidine derivatives useful as h3 receptor modulators
MX2012003389A (es) Moduladores de gpr40 de pirrolidina.
NO20091741L (no) Pyrazolinforbindelser som mineralkortikoidreceptorantagonister
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
MY151003A (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
MX2011011776A (es) Nuevos profarmacos de triptolite.
MY187718A (en) Pharmaceutical formulations
TN2012000105A1 (en) Spirolactam derivatives and uses of same
MX2009012518A (es) Derivados de piperidina 4,4-disubstituidos.
MX2013006768A (es) Moduladores de receptor de glucagon.
MX2008002805A (es) Derivados de carboxamida como antagonistas del receptor muscarinico.
MX2010007929A (es) Imidazolinilmetil aril sulfonamidas novedosas.
EA201270556A1 (ru) Конденсированные тиазоло и оксазолопиримидиноны
MX2012007005A (es) Tiazoles biciclicos como moduladores alostericos de recptores de glutamato metabotropico subtipo 5.
ATE546448T1 (de) Urotensin-ii-rezeptorantagonisten
ATE461172T1 (de) Azetidinderivate als antagonisten des muskarinrezeptors

Legal Events

Date Code Title Description
FA Abandonment or withdrawal